Evidence map›Paper›PMID 35022174›Full record

ArticleBMJ open2022

Strengthening the quality of clinical trials of acupuncture: a guideline protocol.

Ying He, Juan Li, Yuxi Li, Rongjiang Jin, Qian Wen, Ning Li, Yonggang Zhang

Abstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ying He *Department of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, China.ORCID 0000-0002-3999-2655
Juan Li *Acu-moxibustion and Tuina school, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.ORCID 0000-0002-8530-9001
Yuxi LiAcu-moxibustion and Tuina school, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.ORCID 0000-0002-6451-7311
Rongjiang JinAcu-moxibustion and Tuina school, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Qian WenDepartment of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, China.ORCID 0000-0002-4035-2903
Ning LiDepartment of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, China jebm_zhang@yahoo.com zhenjiuhuaxi@163.com.ORCID 0000-0001-9632-3944
Yonggang ZhangDepartment of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, China jebm_zhang@yahoo.com zhenjiuhuaxi@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAcupuncture has been accepted in many Western countries and clinical trials have been increasing recently. However, the problems of insufficient and low-quality evidence remain, and substantially hinder the development of acupuncture clinical trials. We therefore aim to develop a guideline to strengthen the quality of acupuncture clinical trials, in accordance with WHO handbook for guideline development and the Reporting Items for practice Guidelines in HealThcare. The guideline will help to improve the quality of acupuncture clinical trials. METHODS AND ANALYSIS: We will search for studies on the quality of acupuncture clinical trials using PubMed, EMBASE, Web of Science, China National Knowledge Infrastructure, Wanfang Data, China Science and Technology Journal Database, The Cochrane Library, the WHO and Health Technology Assessment websites, and other sources. We will also check reference lists and contact experts in the field. We will systematically evaluate the quality of acupuncture clinical trials, and extract and summarise the quality problems and countermeasures of such trials. We will also systematically review clinical trial quality control manuals and systems and formulate research questions on quality control in acupuncture clinical trials. Finally, we will develop the guideline and establish a comprehensive quality control system to ensure high quality acupuncture clinical trials. We will also evaluate the guideline and will update the guideline to reflect new scientific evidence. ETHICS AND DISSEMINATION: Ethics committee approval and informed consent are not required for developing guideline because only published data will be used, however, we will interview the patients, the ethics committee approval has been got from West China Hospital of Sichuan Unversity (Number: 2021-1188). We will publish all manuscripts arising from this research and present the findings at conferences. GUIDELINE REGISTRATION NUMBER: IPGRP-2021CN093.

Indexed as

Acupuncture TherapyChinaClinical Trials as TopicGuidelines as TopicHumanscomplementary medicineprotocols & guidelinesstatistics & research methods

Identifiers

PMID35022174
PMCPMC8756270

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.